UPDATE 1-Novartis, GBT sickle cell drugs too expensive, draft U.S. report says
January 24, 2020 at 12:02 PM EST
* Report may change after public comments (Adds share prices for Novartis, GBT in 8th paragraph)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
